Ryvu Therapeutics SA
RYVU (RVU)
26.3500
0.0500
(0.19%)
15.12.2025
| Shareholder Name | The amount of shares | Market price | Shares in percents | Voices per WZA in percents |
|---|---|---|---|---|
| Przewięźlikowski Paweł | 4 082 544 | 107 575 034.40 zł | 17.66% | 27.91% |
| Allianz Polska OFE | 2 132 540 | 56 192 429.00 zł | 9.22% | 7.85% |
| BioNTech SE | 1 917 437 | 50 524 464.95 zł | 8.29% | 7.06% |
| NN OFE | 1 900 000 | 50 065 000.00 zł | 8.22% | 6.99% |
| Wesołowski Tadeusz | 1 372 713 | 36 170 987.55 zł | 5.94% | 5.05% |
| Sieczkowski Bogusław | 924 384 | 24 357 518.40 zł | 4.00% | 5.43% |
| Razem | 12 329 618 | 324 885 434.30 zł | 53.33% | 60.29% |
Przewięźlikowski Paweł 4 082 544 107 575 034.40 zł 17.66% 27.91% |
Allianz Polska OFE 2 132 540 56 192 429.00 zł 9.22% 7.85% |
BioNTech SE 1 917 437 50 524 464.95 zł 8.29% 7.06% |
NN OFE 1 900 000 50 065 000.00 zł 8.22% 6.99% |
Wesołowski Tadeusz 1 372 713 36 170 987.55 zł 5.94% 5.05% |
Sieczkowski Bogusław 924 384 24 357 518.40 zł 4.00% 5.43% |